We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

COPAN DIAGNOSTICS

COPAN (which stands for COllection and Preservation for ANalysis) is a global market leader in sample collection and ... read more Featured Products: More products

Download Mobile App





Copan Showcases Fully Automated Solutions for Antibiotic Susceptibility Testing at ECCMID 2022

By LabMedica International staff writers
Posted on 25 Apr 2022
Print article
Image: COPAN Colibri System (Photo courtesy of COPAN Diagnostics)
Image: COPAN Colibri System (Photo courtesy of COPAN Diagnostics)

COPAN Diagnostics (Murrieta, CA, USA) showcased its range of fully automated solutions for identification and antimicrobial susceptibility testing (AST) in clinical microbiology at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022).

COPAN demonstrated the FDA-cleared Colibri, a fully automated specimen workup instrument designed to prepare MALDI-TOF ID targets and create bacterial suspensions for AST. Colibri is an in vitro diagnostic device for use with the bioMérieux VITEK MS or Bruker MALDI Biotyper CA mass spectrometry systems. It automatically picks isolated colonies for further workup and investigations. Colibri can also seed colonies into various size tubes or bottles to prepare McFarland suspensions for AST, verifying opacity of suspensions using the onboard nephelometer. The system applies barcode labels to tubes and prepares purity check plates from these suspensions.

Colibri is paired with COPAN’s artificial intelligence (AI) software, PhenoMATRIX, to offer clinical microbiology laboratories cutting-edge, intelligence driven solutions for specimen workup to help streamline workflow and address the most challenging demands in the laboratory. PhenoMATRIX TAG colony selection software automatically chooses isolated colonies on plated media for picking. By grouping negative cultures, which represent the majority of cultures screened, Microbiologists can quickly review up to 40 plates at a time and batch release negative results quickly. Eliminating the need to review each plate manually, saves precious time and allows technicians to focus on complex cultures which require their unique expertise, and to consult with physicians to provide better patient care.

COPAN also exhibited its UniVerse fully automated instrument for molecular specimen preparation. UniVerse revolutionizes up front sample processing for molecular diagnostics automatically managing accessioning, labeling, vortexing, and aliquoting into assay tubes and 96-well plates. UniVerse is fully LIS interfaced, it increases laboratory throughput with complete traceability, reliability and accuracy. It increases productivity while decreasing operational cost and allows valuable human resources to be re-deployed to higher level tasks.

Related Links:
COPAN Diagnostics 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The test can find tRNA fragments unique to Parkinson’s disease before patients even have symptoms (Photo courtesy of Shutterstock)

Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease

Currently, no reliable blood test exists for diagnosing Parkinson’s disease. Instead, physicians rely on observing a patient's movements, but this qualitative method has an error rate of 20%-25% and can... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.